Asha N. Talati

Dr. Asha N. Talati, an expert in maternal fetal medicine and genetic counseling at UNC, joins to discuss the latest advancements in pregnancy management for individuals with cystic fibrosis. They explore the impact of effective modulator therapies on fertility and reduced preterm birth risks. The conversation highlights innovations in prenatal care, including randomized trials on postpartum hemorrhage and the genetic considerations affecting maternal health. Critical ethical questions surrounding expensive treatments and the importance of informed counseling are also addressed.

Dr. Asha N. Talati, an assistant professor specializing in maternal fetal medicine and clinical genetics at UNC, delves into groundbreaking research on managing pregnancy in cystic fibrosis patients. She discusses the transformative effects of highly effective modulator therapies on pregnancy outcomes. The conversation covers prenatal genetic counseling, the ethical implications of fetal treatment, and the balancing act of breastfeeding while on medication. Dr. Talati emphasizes the importance of informed reproductive planning for both parents and healthcare providers.